electroCore Provides Select Third Quarter 2022 Financial Guidance
ROCKAWAY, N.J., Oct. 14, 2022 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”) (Nasdaq:ECOR), a commercial-stage bioelectronic medicine company, today provided select unaudited preliminary financial guidance for the third quarter of 2022.
Related news for (ECOR)
- electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
- electroCore’s Truvaga™ Now Works with the Apple Health app
- electroCore Named One of The Americas’ Fastest Growing Companies by the Financial Times
- electroCore Extends VA Contract for Five Years
- electroCore Announces Full Year 2024 Financial Results